Availability and affordability of metformin 500mg and 850mg tabs, lowest priced generics, by sector and country.

<p>AF Afghanistan, BI Burundi, BO Bolivia, BR Brazil Rio Grande de Sol, CH China Shaanxi Province, CO Colombia, EC Ecuador, ID Indonesia, IN India Delhi, IR Iran, KG Kyrgyzstan, LA Lao PDR, LE Lebanon, MA Mauritius, ME Mexico City, MO Mongolia, SU Sudan, TA Tanzania, TJ Tajikistan, UG Uganda, UK Ukraine. Note: medicines in the public sector in BR, EC, ME, IN, UG, CO, LE and MA were dispensed free-of-charge to all patients in the outlets sampled so days’ wages are indicated as 0.</p

Surveys in secondary analysis of NCD medicine availability and affordability.

<p>Surveys in secondary analysis of NCD medicine availability and affordability.</p

Median number of days’ wages needed to purchase standard treatments, by World Bank Income Group.

<p>Median number of days’ wages needed to purchase standard treatments, by World Bank Income Group.</p

Percentage of data points where medicines were both available and affordable, by World Bank Income Group.

<p>Percentage of data points where medicines were both available and affordable, by World Bank Income Group.</p

Additional file 1: of Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology

Supplementary details on survey methods, data and statistical analyses. (PDF 874 kb

Percentage cause of not meeting the WHO target (poor availability, poor affordability, or both).

<p>Percentage cause of not meeting the WHO target (poor availability, poor affordability, or both).</p

Median percentage availability by World Bank Income Group.

<p>Median percentage availability by World Bank Income Group.</p

Median availability of surveyed medicines.

<p>IQR = interquartile range.</p

Median availability of any product type (originator brand/generic) of essential and non-essential medicines by ATC categories.

<p>*Ectoparasiticides, including scabicides, insecticides and repellents, **Anti-inflammatory and anti-rheumatic products, ***Agents acting on the renin-angiotensin system.</p

Countries and surveys included in the study.

<p>*As at the time of the survey. LIC: low income country, LMIC: lower middle income country, UMIC: upper middle income country.</p><p>**Data is closest to the year of the survey.</p>†<p>2003–2005.</p